Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Rapid Acting Insulin Market Report by Product (Lispro Insulin, Aspart Insulin, Glulisine Insulin), Indication (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A4783
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Rapid Acting Insulin Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Lispro Insulin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aspart Insulin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Glulisine Insulin
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Indication
7.1 Type 1 Diabetes
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Type 2 Diabetes
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Stores and Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Adocia
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Biocon Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Eli Lilly and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Gan & Lee Pharmaceuticals Co. Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Geropharm
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 MannKind Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Merck & Co. Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Novo Nordisk A/S
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Wockhardt Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
List of Figures
Figure 1: Global: Rapid Acting Insulin Market: Major Drivers and Challenges
Figure 2: Global: Rapid Acting Insulin Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Rapid Acting Insulin Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Rapid Acting Insulin Market: Breakup by Product (in %), 2023
Figure 5: Global: Rapid Acting Insulin Market: Breakup by Indication (in %), 2023
Figure 6: Global: Rapid Acting Insulin Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Rapid Acting Insulin Market: Breakup by Region (in %), 2023
Figure 8: Global: Rapid Acting Insulin (Lispro Insulin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Rapid Acting Insulin (Lispro Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Rapid Acting Insulin (Aspart Insulin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Rapid Acting Insulin (Aspart Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Rapid Acting Insulin (Glulisine Insulin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Rapid Acting Insulin (Glulisine Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Rapid Acting Insulin (Type 1 Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Rapid Acting Insulin (Type 1 Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Rapid Acting Insulin (Type 2 Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Rapid Acting Insulin (Type 2 Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Rapid Acting Insulin (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Rapid Acting Insulin (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Rapid Acting Insulin (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Rapid Acting Insulin (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Rapid Acting Insulin (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Rapid Acting Insulin (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: North America: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: North America: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: United States: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: United States: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Canada: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Canada: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Asia-Pacific: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Asia-Pacific: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: China: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: China: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Japan: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Japan: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: India: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: India: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: South Korea: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: South Korea: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Australia: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Australia: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Indonesia: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Indonesia: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Others: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Others: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Europe: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Europe: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Germany: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Germany: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: France: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: France: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: United Kingdom: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: United Kingdom: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Italy: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Italy: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Spain: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Spain: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Russia: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Russia: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Latin America: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Latin America: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Brazil: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Brazil: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Mexico: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Mexico: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Middle East and Africa: Rapid Acting Insulin Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Middle East and Africa: Rapid Acting Insulin Market: Breakup by Country (in %), 2023
Figure 72: Middle East and Africa: Rapid Acting Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Global: Rapid Acting Insulin Industry: SWOT Analysis
Figure 74: Global: Rapid Acting Insulin Industry: Value Chain Analysis
Figure 75: Global: Rapid Acting Insulin Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Rapid Acting Insulin Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Rapid Acting Insulin Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Rapid Acting Insulin Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 4: Global: Rapid Acting Insulin Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Rapid Acting Insulin Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Rapid Acting Insulin Market: Competitive Structure
Table 7: Global: Rapid Acting Insulin Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More